Postepy Higieny i Medycyny Doswiadczalnej : Impact Factor & More
eISSN: 1732-2693pISSN: 0032-5449
Share this on:
Key Metrics
CiteScore 
0.5
Impact Factor
< 5
SJR
Q3Infectious Diseases
SNIP
0.12
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Postepy Higieny i Medycyny Doswiadczalnej
Postepy Higieny i Medycyny Doswiadczalnej Journal Specifications
| Overview | |
| Publisher | POLISH ACAD SCIENCES, INST IMMUNOL & EXP THERAPY |
| Language | Polish,English |
| Frequency | Annual |
| General Details | |
| Language | Polish,English |
| Frequency | Annual |
| Publication Start Year | 1949 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Postepy Higieny i Medycyny Doswiadczalnej ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Postepy Higieny i Medycyny Doswiadczalnej
Circumventing vascular barriers for effective immunotherapy in brain tumors – focus on glioblastoma
- 1 Jan 2025
- Postępy Higieny i Medycyny Doświadczalnej
Determinants of obesity stigma in the 21st century
- 1 Jan 2025
- Postępy Higieny i Medycyny Doświadczalnej
EGF enema and EGFR monoclonal antibody injection alleviate the inflammatory bowel disease in AMO/DSS induced mice model
- 1 Jan 2025
- Postępy Higieny i Medycyny Doświadczalnej
A tendency to maintain a stable level of sulfane sulfur under various environmental or culture conditions
- 1 Jan 2025
- Postępy Higieny i Medycyny Doświadczalnej
To assess the efficacy and safety of non-vitamin K antagonist oral anticoagulant rivaroxaban in patients with non-valvular atrial fibrillation
- 1 Jan 2025
- Postępy Higieny i Medycyny Doświadczalnej
Analysis of mercury content in fish and its impact on human health in the context of omega-3 and omega-6 fatty acid (DHA, EPA) supplementation derived from fish oil
- 1 Jan 2025
- Postępy Higieny i Medycyny Doświadczalnej
Circumventing vascular barriers for effective immunotherapy in brain tumors – focus on glioblastoma
- 1 Jan 2025
- Postępy Higieny i Medycyny Doświadczalnej
Determinants of obesity stigma in the 21st century
- 1 Jan 2025
- Postępy Higieny i Medycyny Doświadczalnej
EGF enema and EGFR monoclonal antibody injection alleviate the inflammatory bowel disease in AMO/DSS induced mice model
- 1 Jan 2025
- Postępy Higieny i Medycyny Doświadczalnej
A tendency to maintain a stable level of sulfane sulfur under various environmental or culture conditions
- 1 Jan 2025
- Postępy Higieny i Medycyny Doświadczalnej
To assess the efficacy and safety of non-vitamin K antagonist oral anticoagulant rivaroxaban in patients with non-valvular atrial fibrillation
- 1 Jan 2025
- Postępy Higieny i Medycyny Doświadczalnej
Analysis of mercury content in fish and its impact on human health in the context of omega-3 and omega-6 fatty acid (DHA, EPA) supplementation derived from fish oil
- 1 Jan 2025
- Postępy Higieny i Medycyny Doświadczalnej
FAQs on Postepy Higieny i Medycyny Doswiadczalnej
How long has Postepy Higieny i Medycyny Doswiadczalnej been actively publishing? 
What is the publishing frequency of Postepy Higieny i Medycyny Doswiadczalnej?
How many articles did Postepy Higieny i Medycyny Doswiadczalnej publish last year?
What is the eISSN & pISSN for Postepy Higieny i Medycyny Doswiadczalnej?
What is Citescore for Postepy Higieny i Medycyny Doswiadczalnej?
What is SNIP score for Postepy Higieny i Medycyny Doswiadczalnej?
What is the SJR for Postepy Higieny i Medycyny Doswiadczalnej?
Who is the publisher of Postepy Higieny i Medycyny Doswiadczalnej?
